DrugCite

Betaseron and Musculoskeletal Stiffness

This page shows results related to Betaseron and Musculoskeletal Stiffness from the FDA Adverse Event Reporting System (AERS).

Click here to learn about all Betaseron adverse events.

Adverse Event
Safe Use Tools
Learn More
Comments

Betaseron and Musculoskeletal Stiffness

Age

40-49 Years
49
50-59 Years
44
>60 Years
41
30-39 Years
10
20-29 Years
7

Gender

Male: 15%
Female: 82%
Gender Unknown: 3%

Outcome

What were the most common outcomes of those reporting Musculoskeletal Stiffness?

Other
75
Hospitalization
45
Death
25
Disability
11

Reporter

Who most commonly reported Musculoskeletal Stiffness?

Consumer
61
Other
32
Physician
10
Pharmacist
2

Therapy

Of those reporting Musculoskeletal Stiffness, why were they taking Betaseron?

Multiple Sclerosis
50
Relapsing-remitting Multiple Sclero...
31
Drug Use For Unknown Indication
13
Secondary Progressive Multiple Scle...
12
Primary Progressive Multiple Sclero...
5

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.*

YESNOUNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?
Probability of an Adverse Event
Doubtful
Possible
Probable
Definite

*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Betaseron, view the complete Betaseron adverse event report.

Scientific Publications on Musculoskeletal Stiffness

Powered by Google

Comments

Share your experience with Betaseron and Musculoskeletal Stiffness.